Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome–Positive (Ph+) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study
Title:
Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome–Positive (Ph+) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study
Author:
Mauro, Michael J. Cortes, Jorge E. Kantarjian, Hagop M. Shah, Neil P. Bixby, Dale Flinn, Ian W. O’Hare, Thomas Hu, Simin Rivera, Victor M. Clackson, Tim Turner, Christopher D. Haluska, Frank G. Druker, Brian J. Deininger, Michael W. Talpaz, Moshe